Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
NCT05020964
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Advanced Breast Cancer
Interventions
DRUG:
Trastuzumab and Pyrotinib
Sponsor
Chinese Academy of Medical Sciences